Validation pour Ingenuity258

vers la météo de la validation par utilisateur

Ingenuity258

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 50 - PMID ?

In liver from SP , oral administration of NODE ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of NODE ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of SP NODE mRNA .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                                                   +--------------------COMP:N-N(with)-------------------+                                                                                                                                                                 
                                                   |                               +---------------------COMP:N-N(of)--------------------+                                                                                                                                 
                                                   |                               +----------COMP:N-N(of)----------+                    +---------------------------COMP:N-N(with)---------------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+              +---------COMP:N-N(with)--------+                     +----------COMP:N-N(of)---------+----------------COMP:N-N(with)----------------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,g/ml)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 1

                                                   +--------------------COMP:N-N(with)-------------------+                                                                                                                                                                 
                                                   |                               +---------------------COMP:N-N(of)--------------------+                                              +--------------------COMP:N-N(of)-------------------+                              
                                                   |                               +----------COMP:N-N(of)----------+------------COMP:N-N(of)-----------+                               |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
                  +------APPOS------+              +---------COMP:N-N(with)--------+                     +----------COMP:N-N(of)---------+              +-------COMP:N-N(of)------+     |                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+        |     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,@card@)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 2

                                                                                                                    +--------------------------------------COMP:N-N(with)-------------------------------------+                                                            
                                                                                                                    |                    +---------------------------COMP:N-N(with)---------------------------+                                                            
                                                                                                                    +---------------------------COMP:N-N(with)--------------------------+                     |                                                            
                                                                                   +---------------------COMP:N-N(of)--------------------+                                              +--------------------COMP:N-N(of)-------------------+                              
                                                                                   +----------COMP:N-N(of)----------+------------COMP:N-N(of)-----------+                               |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+----------------COMP:N-N(with)----------------+                     +----------COMP:N-N(of)---------+----------------COMP:N-N(with)----------------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,g/ml)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,g/ml)
COMP:N-N(with) (week,period)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,g/ml)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 3

                                                                                   +---------------------COMP:N-N(of)--------------------+                                              +--------------------COMP:N-N(of)-------------------+                              
      +--------COMP:N-N(from)-------+                                              +----------COMP:N-N(of)----------+                    |                                              |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+                                              |                     +----------COMP:N-N(of)---------+                                              |                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 4

                                                                                                                                                                                        +--------------------COMP:N-N(of)-------------------+                              
      +--------COMP:N-N(from)-------+              +--------------------COMP:N-N(with)-------------------+                                                                              |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+              +---------COMP:N-N(with)--------+----------COMP:N-N(of)----------+-------------------COMP:N-N(with)-------------------+              |                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 5

                                                                                                                                         +---------------------------COMP:N-N(with)---------------------------+                                                            
                                                                                   +---------------------COMP:N-N(of)--------------------+                                              +--------------------COMP:N-N(of)-------------------+                              
                                                                                   +----------COMP:N-N(of)----------+                    |                                              |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+                                              |                     +----------COMP:N-N(of)---------+----------------COMP:N-N(with)----------------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,g/ml)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 6

                                                   +--------------------COMP:N-N(with)-------------------+                                                                                                                                                                 
                                                   |                               +---------------------COMP:N-N(of)--------------------+                                              +--------------------COMP:N-N(of)-------------------+                              
      +----------------COMP:N-N(of)----------------+                               +----------COMP:N-N(of)----------+------------COMP:N-N(of)-----------+                               |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +------APPOS------+              +---------COMP:N-N(with)--------+                     +----------COMP:N-N(of)---------+              +---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+              |                +COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(of) (liver,__NODE__)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 7

                                                                                   +---------------------COMP:N-N(of)--------------------+                                                                                                                                 
                                                                                   +----------COMP:N-N(of)----------+                    |              +--------------------COMP:N-N(with)-------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+              +---------COMP:N-N(with)--------+                     +----------COMP:N-N(of)---------+              +---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 8

                                                                             +------------------------COMP:N-N(of)-----------------------+                                                                                                                                 
      +--------COMP:N-N(from)-------+                                        +-------------COMP:N-N(of)-------------+                    |              +--------------------COMP:N-N(with)-------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+                               +------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+              +---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (@card@,week)
COMP:N-N(of) (@card@,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 9

                                                                                                                                                        +--------------------COMP:N-N(with)-------------------+                                                            
                                                                                                                                                        |                               +--------------------COMP:N-N(of)-------------------+                              
      +--------COMP:N-N(from)-------+                                                                                                                   |                               |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+---------COMP:N-N(with)--------+------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+              +---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 10

      +----------------COMP:N-N(of)----------------+                                                                                                                                                                                                                       
      +--------COMP:N-N(from)-------+              +---------------------COMP:N-N(of)--------------------+                                              +--------------------COMP:N-N(with)-------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+              +----------COMP:N-N(of)---------+                     +----------COMP:N-N(of)---------+              +---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+              +-COMP:N-N(with)-+              |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
COMP:N-N(of) (liver,__NODE__)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,g/ml)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 11

      +----------------COMP:N-N(of)----------------+                                                                                                                                                                                                                       
      +--------COMP:N-N(from)-------+              |                                                                                                    +--------------------COMP:N-N(with)-------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+              |                +------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+              +---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+              +-COMP:N-N(with)-+-COMP:N-N(of)-+            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
COMP:N-N(of) (liver,__NODE__)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 12

                                                                                                                                                        +--------------------COMP:N-N(with)-------------------+                                                            
      +----------------COMP:N-N(of)----------------+                                                                                                    |                               +--------------------COMP:N-N(of)-------------------+                              
      +--------COMP:N-N(from)-------+              |                                                                +------------COMP:N-N(of)-----------+                               |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+              |                +------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+              +---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+              +------APPOS-----+COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
COMP:N-N(of) (liver,__NODE__)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 13

      +--------COMP:N-N(from)-------+                                                                               +------------COMP:N-N(of)-----------+--------------------COMP:N-N(with)-------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+-------------APPOS-------------+------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+              +---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 14

                                                                                   +---------------------COMP:N-N(of)--------------------+                                                                                                                                 
      +----------------COMP:N-N(of)----------------+                               |                                +-------------------COMP:N-N(with)-------------------+              +--------------------COMP:N-N(of)-------------------+                              
      +--------COMP:N-N(from)-------+              |                               +----------COMP:N-N(of)----------+------------COMP:N-N(of)-----------+                |              |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+              |                               |                     +----------COMP:N-N(of)---------+---------COMP:N-N(with)--------+------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+              +-COMP:N-N(with)-+COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
COMP:N-N(of) (liver,__NODE__)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 15

      +----------------COMP:N-N(of)----------------+                         +------------------------COMP:N-N(of)-----------------------+                                              +--------------------COMP:N-N(of)-------------------+                              
      +--------COMP:N-N(from)-------+              |                         +-------------COMP:N-N(of)-------------+------------COMP:N-N(of)-----------+                               |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+              |                +------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+              +---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+              +-COMP:N-N(with)-+COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
COMP:N-N(of) (liver,__NODE__)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (@card@,week)
COMP:N-N(of) (@card@,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 16

                                                                                                                                                        +--------------------COMP:N-N(with)-------------------+                                                            
                                                                                                                                                        |                               +--------------------COMP:N-N(of)-------------------+                              
      +----------------COMP:N-N(of)----------------+                                                                +------------COMP:N-N(of)-----------+                               |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +------APPOS------+              |                +------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+              +---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+              +-COMP:N-N(with)-+COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(of) (liver,__NODE__)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 17

                                    +---------------------------COMP:N-N(with)---------------------------+                                                                                                                                                                 
                                    |                                              +---------------------COMP:N-N(of)--------------------+                                                                                                                                 
                                    |                                              +----------COMP:N-N(of)----------+                    +---------------------------COMP:N-N(with)---------------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
                  +------APPOS------+----------------COMP:N-N(with)----------------+                     +----------COMP:N-N(of)---------+---------COMP:N-N(with)--------+                                    |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,g/ml)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,g/ml)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 18

                                                   +---------------------COMP:N-N(of)--------------------+                                                                                                                                                                 
                                                   |                               +---------------------COMP:N-N(of)--------------------+                                                                                                                                 
      +----------------COMP:N-N(of)----------------+                               +----------COMP:N-N(of)----------+                    |              +--------------------COMP:N-N(with)-------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +------APPOS------+              +----------COMP:N-N(of)---------+                     +----------COMP:N-N(of)---------+              +---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+              +-COMP:N-N(with)-+              |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(of) (liver,__NODE__)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,g/ml)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 19

                                    +---------------------------COMP:N-N(with)---------------------------+          +------------COMP:N-N(of)-----------+--------------------COMP:N-N(with)-------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+---------COMP:N-N(with)--------+                                    +----------COMP:N-N(of)---------+              +---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,g/ml)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 20

                                                                                                                    +--------------------------------------COMP:N-N(with)-------------------------------------+                                                            
                                                                                                                    |                    +---------------------------COMP:N-N(with)---------------------------+                                                            
                                                                                                                    +-------------------COMP:N-N(with)-------------------+                                    |                                                            
                                                   +--------------------COMP:N-N(with)-------------------+          +------------COMP:N-N(of)-----------+                |                                    +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+              +---------COMP:N-N(with)--------+                     +----------COMP:N-N(of)---------+---------COMP:N-N(with)--------+                                    |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
COMP:N-N(with) (week,period)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 21

                                    +---------------------------COMP:N-N(with)---------------------------+                                              +--------------------COMP:N-N(with)-------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+---------COMP:N-N(with)--------+                                    +----------COMP:N-N(of)---------+              +---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 22

                                                                                                                                                        +--------------------COMP:N-N(with)-------------------+                                                            
                                                                                                                                                        |                               +--------------------COMP:N-N(of)-------------------+                              
                                                                                                         +----------COMP:N-N(of)---------+              |                               |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
                  +------APPOS------+-------------APPOS-------------+------------COMP:N-N(of)------------+          +-----MOD_ATT:N-N----+              +---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+          |          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,week)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 23

                                                                                   +---------------------COMP:N-N(of)--------------------+                                                                                                                                 
      +--------COMP:N-N(from)-------+                                              +----------COMP:N-N(of)----------+                    |                                                                    +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+----------------COMP:N-N(with)----------------+                     +----------COMP:N-N(of)---------+                               +------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+------APPOS-----+-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,g/ml)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 24

                                                                                                                                         +---------------------------COMP:N-N(with)---------------------------+                                                            
                                                                                                                                         |                                              +--------------------COMP:N-N(of)-------------------+                              
                                                                                                                                         |                                              |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
                  +------APPOS------+-------------APPOS-------------+------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+----------------COMP:N-N(with)----------------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,g/ml)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 25

                                                                                                                                                        +--------------------COMP:N-N(with)-------------------+                                                            
                                                                             +------------------------COMP:N-N(of)-----------------------+              |                               +--------------------COMP:N-N(of)-------------------+                              
                                                                             +-------------COMP:N-N(of)-------------+------------COMP:N-N(of)-----------+                               |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
                  +------APPOS------+                                        |                           +----------COMP:N-N(of)---------+              +---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (@card@,week)
COMP:N-N(of) (@card@,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 26

                                                   +--------------------COMP:N-N(with)-------------------+                                                                                                                                                                 
                                                   |                               +---------------------COMP:N-N(of)--------------------+                                              +--------------------COMP:N-N(of)-------------------+                              
                                                   |                               +----------COMP:N-N(of)----------+------------COMP:N-N(of)-----------+                               |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
                  +------APPOS------+              +---------COMP:N-N(with)--------+                     +----------COMP:N-N(of)---------+              |                               |                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 27

                                                                                   +---------------------COMP:N-N(of)--------------------+                                              +--------------------COMP:N-N(of)-------------------+                              
                                                                                   +----------COMP:N-N(of)----------+                    |                                              |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
                  +------APPOS------+              +---------COMP:N-N(with)--------+                     +----------COMP:N-N(of)---------+---------COMP:N-N(with)--------+------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 28

      +--------COMP:N-N(from)-------+                                                                                                                   +--------------------COMP:N-N(with)-------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+                                        +-------------COMP:N-N(of)-------------+------------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (@card@,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 29

                                                                                   +---------------------COMP:N-N(of)--------------------+                                                                                                                                 
                                                                                   +----------COMP:N-N(of)----------+                    |              +--------------------COMP:N-N(with)-------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+              +----------COMP:N-N(of)---------+                     +----------COMP:N-N(of)---------+              +---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+              |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,g/ml)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 30

                                                                                   +---------------------COMP:N-N(of)--------------------+                                                                                                                                 
                                                                                   +----------COMP:N-N(of)----------+------------COMP:N-N(of)-----------+---------------------COMP:N-N(of)--------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
                  +------APPOS------+                                              |                     +----------COMP:N-N(of)---------+              +-------COMP:N-N(of)------+                           |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+------APPOS-----+COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+        |                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,@card@)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 31

                                                                                   +---------------------COMP:N-N(of)--------------------+                                                                                                                                 
                                                                                   |                                +-------------------COMP:N-N(with)-------------------+              +--------------------COMP:N-N(of)-------------------+                              
      +--------COMP:N-N(from)-------+                                              +----------COMP:N-N(of)----------+------------COMP:N-N(of)-----------+                |              |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+-------------APPOS-------------+              |                     +----------COMP:N-N(of)---------+---------COMP:N-N(with)--------+              |                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 32

                                                                                   +---------------------COMP:N-N(of)--------------------+                                              +--------------------COMP:N-N(of)-------------------+                              
      +----------------COMP:N-N(of)----------------+                               +----------COMP:N-N(of)----------+                    |                                              |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +------APPOS------+              +-------COMP:N-N(of)------+     |                     +----------COMP:N-N(of)---------+                               +------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+              +-COMP:N-N(with)-+        |     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+------APPOS-----+-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(of) (liver,__NODE__)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,@card@)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 33

                                                                                   +---------------------COMP:N-N(of)--------------------+                                        +-----------------------COMP:N-N(of)----------------------+                              
                                                                                   |                     +----------COMP:N-N(of)---------+                                        |                           +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
                  +------APPOS------+----------------COMP:N-N(with)----------------+                     |          +-----MOD_ATT:N-N----+              +-------COMP:N-N(of)------+                           |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+        |                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,g/ml)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,week)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,@card@)
COMP:N-N(of) (@card@,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 34

                                                                                                                                                                                        +--------------------COMP:N-N(of)-------------------+                              
                                                   +---------------------COMP:N-N(of)--------------------+                                                                              |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
                  +------APPOS------+              +-------COMP:N-N(of)------+-------------COMP:N-N(of)-------------+------------COMP:N-N(of)-----------+---------COMP:N-N(with)--------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+        |                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,@card@)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (@card@,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,g/ml)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 35

      +----------------COMP:N-N(of)----------------+                                                                                                                                                          +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +------APPOS------+              |                               +----------COMP:N-N(of)----------+------------COMP:N-N(of)-----------+                +------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+              +------APPOS-----+COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(of) (liver,__NODE__)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 36

      +----------------COMP:N-N(of)----------------+                                                                                                                                                          +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +------APPOS------+              +-------COMP:N-N(of)------+     +----------COMP:N-N(of)----------+------------COMP:N-N(of)-----------+                +------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+              +-COMP:N-N(with)-+        |     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+------APPOS-----+COMP:N-N+                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(of) (liver,__NODE__)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,@card@)
COMP:N-N(of) (g/ml,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 37

                                                                                                                                                                                                              +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+                                              +----------COMP:N-N(of)----------+------------COMP:N-N(of)-----------+                +------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+------APPOS-----+COMP:N-N+     |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+------APPOS-----+-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |     |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 38

                                                                                   +---------------------COMP:N-N(of)--------------------+                                              +--------------------COMP:N-N(of)-------------------+                              
      +----------------COMP:N-N(of)----------------+                               +----------COMP:N-N(of)----------+                    |                                              |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +------APPOS------+              |                               |                     +----------COMP:N-N(of)---------+-------------APPOS-------------+              |                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+              +------APPOS-----+-COMP:N-N(of)-+            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+     |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |        |     |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(of) (liver,__NODE__)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 39

                                                                                                                                                                                  +-----------------------COMP:N-N(of)----------------------+                              
      +--------COMP:N-N(from)-------+              +---------------------COMP:N-N(of)--------------------+          +------------COMP:N-N(of)-----------+---------------------COMP:N-N(of)--------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+              +----------COMP:N-N(of)---------+                     +----------COMP:N-N(of)---------+              +-------COMP:N-N(of)------+                           |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+              |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+        |                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,g/ml)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,@card@)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (@card@,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 40

      +--------COMP:N-N(from)-------+                                                                               +------------COMP:N-N(of)-----------+---------------------COMP:N-N(of)--------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+                               +------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+              +----------COMP:N-N(of)---------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+              |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,g/ml)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 41

                                                                                                                                                                                  +-----------------------COMP:N-N(of)----------------------+                              
      +--------COMP:N-N(from)-------+                                                                                                                                             |                           +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+---------COMP:N-N(with)--------+------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+---------COMP:N-N(with)--------+------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (@card@,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 42

      +--------COMP:N-N(from)-------+---------------------------COMP:N-N(with)---------------------------+                                                                                                    +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+---------COMP:N-N(with)--------+                                    +----------COMP:N-N(of)---------+              +--------------------COMP:N-N(with)-------------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,g/ml)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 43

      +----------------COMP:N-N(of)----------------+                                                                                                                                                                                                                       
      +--------COMP:N-N(from)-------+              |                                                     +----------COMP:N-N(of)---------+                                                                    +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+              +--------------------COMP:N-N(with)-------------------+          +-----MOD_ATT:N-N----+                               +------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+              +-COMP:N-N(with)-+-COMP:N-N(of)-+            +MOD_ATT:+          |          +MOD_ATT:N+-COMP:N-N(of)-+------APPOS-----+-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
COMP:N-N(of) (liver,__NODE__)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,g/ml)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,week)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 44

      +----------------COMP:N-N(of)----------------+                                                                                                                                                                                                                       
      +--------COMP:N-N(from)-------+              |                                                                                                                                                          +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+              +--------------------COMP:N-N(with)-------------------+----------COMP:N-N(of)---------+                               +------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+              +-COMP:N-N(with)-+-COMP:N-N(of)-+            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+------APPOS-----+-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
COMP:N-N(of) (liver,__NODE__)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,g/ml)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 45

                                                                             +------------------------COMP:N-N(of)-----------------------+                                        +-----------------------COMP:N-N(of)----------------------+                              
      +--------COMP:N-N(from)-------+                                        |                           +----------COMP:N-N(of)---------+                                        |                           +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+              +-------COMP:N-N(of)------+                           |          +-----MOD_ATT:N-N----+                               +------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+        |                  +MOD_ATT:+          |          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N+                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,@card@)
COMP:N-N(of) (@card@,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,week)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (@card@,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 46

                                                   +---------------------COMP:N-N(of)--------------------+                                                                                                                                                                 
                                                   |                               +---------------------COMP:N-N(of)--------------------+                                                                                                                                 
      +----------------COMP:N-N(of)----------------+                               +----------COMP:N-N(of)----------+------------COMP:N-N(of)-----------+                                                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +------APPOS------+              +----------COMP:N-N(of)---------+                     +----------COMP:N-N(of)---------+              |                +------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+              +-COMP:N-N(with)-+              |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N+                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(of) (liver,__NODE__)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,g/ml)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 47

                                                                                                                    +--------------------------------------COMP:N-N(with)-------------------------------------+                                                            
                                                                             +------------------------COMP:N-N(of)-----------------------+---------------------------COMP:N-N(with)---------------------------+                                                            
                                                                             |                                      +-------------------COMP:N-N(with)-------------------+                                    |                                                            
      +--------COMP:N-N(from)-------+                                        +-------------COMP:N-N(of)-------------+------------COMP:N-N(of)-----------+                |                                    +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+---------COMP:N-N(with)--------+        |                           +----------COMP:N-N(of)---------+---------COMP:N-N(with)--------+                                    |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (@card@,week)
COMP:N-N(of) (@card@,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
COMP:N-N(with) (week,period)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,g/ml)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 48

                                                                                   +---------------------COMP:N-N(of)--------------------+                                                                                                                                 
                                                                    +------------COMP:N-N(of)------------+                               |                                              +--------------------COMP:N-N(of)-------------------+                              
                                                                    |              +----------COMP:N-N(of)----------+                    |                                              |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
                  +------APPOS------+                               |              |                     +----------COMP:N-N(of)---------+---------COMP:N-N(with)--------+------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+-COMP:N-N(of)-+            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 49

                                                                                                                    +-------------------COMP:N-N(with)-------------------+        +-----------------------COMP:N-N(of)----------------------+                              
      +----------------COMP:N-N(of)----------------+---------------------COMP:N-N(of)--------------------+          +------------COMP:N-N(of)-----------+                |        |                           +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +------APPOS------+              +-------COMP:N-N(of)------+                           +----------COMP:N-N(of)---------+---------COMP:N-N(with)--------+------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+              +-COMP:N-N(with)-+        |                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(of) (liver,__NODE__)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,@card@)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (@card@,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 50

                                                                             +------------------------COMP:N-N(of)-----------------------+                                        +-----------------------COMP:N-N(of)----------------------+                              
      +--------COMP:N-N(from)-------+                                        +-------------COMP:N-N(of)-------------+                    |                                        |                           +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+              +-------COMP:N-N(of)------+                           +----------COMP:N-N(of)---------+---------COMP:N-N(with)--------+------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+        |                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,@card@)
COMP:N-N(of) (@card@,week)
COMP:N-N(of) (@card@,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (@card@,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 51

                                                                                   +---------------------COMP:N-N(of)--------------------+                                                                                                                                 
                                                                    +------------COMP:N-N(of)------------+                               |                                                                                                                                 
                                                                    |              +----------COMP:N-N(of)----------+                    |              +---------------------COMP:N-N(of)--------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
                  +------APPOS------+---------COMP:N-N(with)--------+              |                     +----------COMP:N-N(of)---------+              +----------COMP:N-N(of)---------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+              |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,g/ml)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 52

                                                                             +------------------------COMP:N-N(of)-----------------------+                                        +-----------------------COMP:N-N(of)----------------------+                              
                                                                             +-------------COMP:N-N(of)-------------+------------COMP:N-N(of)-----------+---------------------COMP:N-N(of)--------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+                               +------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+              +-------COMP:N-N(of)------+                           |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+------APPOS-----+COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+        |                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (@card@,week)
COMP:N-N(of) (@card@,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,@card@)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (@card@,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 53

                                                                             +------------------------COMP:N-N(of)-----------------------+                                                                                                                                 
                                                                             +-------------COMP:N-N(of)-------------+------------COMP:N-N(of)-----------+---------------------COMP:N-N(of)--------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+-------------APPOS-------------+------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+              +----------COMP:N-N(of)---------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+              |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (@card@,week)
COMP:N-N(of) (@card@,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,g/ml)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 54

                                                                                   +---------------------COMP:N-N(of)--------------------+                                        +-----------------------COMP:N-N(of)----------------------+                              
      +--------COMP:N-N(from)-------+                                              +----------COMP:N-N(of)----------+------------COMP:N-N(of)-----------+                         |                           +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+---------COMP:N-N(with)--------+              |                     +----------COMP:N-N(of)---------+              |                +------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+------APPOS-----+COMP:N-N+                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (@card@,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 55

                                                                                   +---------------------COMP:N-N(of)--------------------+                                                                                                                                 
      +----------------COMP:N-N(of)----------------+                               |                     +----------COMP:N-N(of)---------+                                                                    +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +------APPOS------+              |                +------------COMP:N-N(of)------------+          +-----MOD_ATT:N-N----+                               +------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+              +------APPOS-----+-COMP:N-N(of)-+            +MOD_ATT:+          |          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N+                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(of) (liver,__NODE__)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,week)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 56

      +----------------COMP:N-N(of)----------------+                         +------------------------COMP:N-N(of)-----------------------+                                              +--------------------COMP:N-N(of)-------------------+                              
      +--------COMP:N-N(from)-------+              |                         +-------------COMP:N-N(of)-------------+------------COMP:N-N(of)-----------+                               |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+              |                +------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+              +----------COMP:N-N(of)---------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+              +------APPOS-----+COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+              |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
COMP:N-N(of) (liver,__NODE__)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (@card@,week)
COMP:N-N(of) (@card@,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,g/ml)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 57

                                                                                                                                                        +---------------------COMP:N-N(of)--------------------+                                                            
                                                                                                                                                        |                               +--------------------COMP:N-N(of)-------------------+                              
                                                                                                         +----------COMP:N-N(of)---------+              |                               |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+-------------APPOS-------------+------------COMP:N-N(of)------------+          +-----MOD_ATT:N-N----+              +----------COMP:N-N(of)---------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+          |          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+              |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,week)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,g/ml)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 58

                                                                                                                                                        +---------------------COMP:N-N(of)--------------------+                                                            
                                                                                   +---------------------COMP:N-N(of)--------------------+              |                               +--------------------COMP:N-N(of)-------------------+                              
      +--------COMP:N-N(from)-------+                                              +----------COMP:N-N(of)----------+                    |              |                               |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+-------------APPOS-------------+              |                     +----------COMP:N-N(of)---------+              +----------COMP:N-N(of)---------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+              |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,g/ml)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 59

                                                                                                                    +------------COMP:N-N(of)-----------+                                                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+                               +------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+              +--------------------COMP:N-N(with)-------------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+------APPOS-----+COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+COMP:N-N+                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,@card@)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 60

                                                                                                                                                        +---------------------COMP:N-N(of)--------------------+---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+                               +------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+              +----------COMP:N-N(of)---------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+------APPOS-----+COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+              |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,g/ml)
COMP:N-N(of) (__NODE__,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 61

                                                                             +------------------------COMP:N-N(of)-----------------------+                                                                                                                                 
                                                                             |                           +----------COMP:N-N(of)---------+                                                                    +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+---------COMP:N-N(with)--------+        |                           |          +-----MOD_ATT:N-N----+              +--------------------COMP:N-N(with)-------------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+          |          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (@card@,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,week)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(with) (__NODE__,period)
COMP:N-N(of) (dosage,g/ml)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 62

                                                                                                                    +--------------------------------------COMP:N-N(with)-------------------------------------+                                                            
                                                                             +------------------------COMP:N-N(of)-----------------------+---------------------------COMP:N-N(with)---------------------------+                                                            
                                                                             |                                      +-------------------COMP:N-N(with)-------------------+                                    |                                                            
                                                                             +-------------COMP:N-N(of)-------------+------------COMP:N-N(of)-----------+                |                                    +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+---------COMP:N-N(with)--------+        |                           +----------COMP:N-N(of)---------+---------COMP:N-N(with)--------+                                    |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (@card@,week)
COMP:N-N(of) (@card@,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
COMP:N-N(with) (week,period)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(with) (administration,period)
COMP:N-N(of) (dosage,g/ml)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 63

                                                                                                                    +-------------------COMP:N-N(with)-------------------+              +--------------------COMP:N-N(of)-------------------+                              
                                                   +---------------------COMP:N-N(of)--------------------+          +------------COMP:N-N(of)-----------+                |              |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
                  +------APPOS------+              +----------COMP:N-N(of)---------+----------COMP:N-N(of)----------+                    +---------COMP:N-N(with)--------+------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+              |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,g/ml)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (g/ml,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (week,__NODE__)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 64

                                                                             +------------------------COMP:N-N(of)-----------------------+                                        +-----------------------COMP:N-N(of)----------------------+                              
                                                                             +-------------COMP:N-N(of)-------------+------------COMP:N-N(of)-----------+                         |                           +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+-------------APPOS-------------+------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+              |                +------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+------APPOS-----+COMP:N-N+                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (@card@,week)
COMP:N-N(of) (@card@,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (@card@,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 65

                                                                                   +---------------------COMP:N-N(of)--------------------+                                                                                                                                 
      +--------COMP:N-N(from)-------+                                              +----------COMP:N-N(of)----------+                    |                                                                    +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +--MOD_ATT:N-ADJ--+-------------APPOS-------------+              |                     +----------COMP:N-N(of)---------+-------------APPOS-------------+------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      |           |       +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,administration)
MOD_ATT:N-ADJ (administration,__SP__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 66

                                                                                                                                                                                        +--------------------COMP:N-N(of)-------------------+                              
                                                                                                                                                                                        |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
                  +------APPOS------+                               +------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+-------------APPOS-------------+------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+------APPOS-----+-COMP:N-N(of)-+            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 67

      +----------------COMP:N-N(of)----------------+                                                                                                                                                          +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +------APPOS------+              |                +------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+-------------APPOS-------------+------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+              +------APPOS-----+-COMP:N-N(of)-+            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(of) (liver,__NODE__)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 68

                                                                                   +---------------------COMP:N-N(of)--------------------+                                        +-----------------------COMP:N-N(of)----------------------+                              
      +----------------COMP:N-N(of)----------------+                               +----------COMP:N-N(of)----------+------------COMP:N-N(of)-----------+                         |                           +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +------APPOS------+              +----------COMP:N-N(of)---------+                     +----------COMP:N-N(of)---------+              |                +------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+              +-COMP:N-N(with)-+              |            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+------APPOS-----+COMP:N-N+                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(of) (liver,__NODE__)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,g/ml)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (@card@,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 69

                                                                    +------------COMP:N-N(of)------------+                                                                                                    +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
                  +------APPOS------+-------------APPOS-------------+              +----------COMP:N-N(of)----------+-------------------COMP:N-N(with)-------------------+------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (g/ml,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 70

                                                                             +------------------------COMP:N-N(of)-----------------------+                                        +-----------------------COMP:N-N(of)----------------------+                              
                                                                             +-------------COMP:N-N(of)-------------+------------COMP:N-N(of)-----------+                         |                           +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+---------COMP:N-N(with)--------+------------COMP:N-N(of)------------+----------COMP:N-N(of)---------+              |                         |                           |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+------APPOS-----+COMP:N-N+                  +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |        |                  |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (@card@,week)
COMP:N-N(of) (@card@,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (@card@,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 71

                                                                                   +---------------------COMP:N-N(of)--------------------+                                              +--------------------COMP:N-N(of)-------------------+                              
                                                                                   +----------COMP:N-N(of)----------+                    |                                              |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
                  +------APPOS------+                                              |                     +----------COMP:N-N(of)---------+---------COMP:N-N(with)--------+------------COMP:N-N(of)------------+          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+------APPOS-----+-COMP:N-N(of)-+            +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+                +-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |              |            |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (__SP__,administration)
MOD_ATT:N-ADJ (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (__NODE__,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (g/ml,week)
COMP:N-N(of) (g/ml,administration)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (period,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (administration,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (dosage,period)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 72

                                                                                                                                                        +---------------------COMP:N-N(of)--------------------+                                                            
                                                                                                                                                        |                               +--------------------COMP:N-N(of)-------------------+                              
                                                                                                                                                        |                               |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      +------------APPOS------------+-------------APPOS-------------+        +-------------COMP:N-N(of)-------------+------------COMP:N-N(of)-----------+----------COMP:N-N(of)---------+                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+-COMP:N-N(of)-+                +COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+              |            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
APPOS (liver,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
APPOS (administration,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (@card@,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(of) (week,__NODE__)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (__NODE__,g/ml)
COMP:N-N(of) (__NODE__,period)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)

Analyse 73

                                                                                                                                                                                        +--------------------COMP:N-N(of)-------------------+                              
      +----------------COMP:N-N(of)----------------+                                                                                                                                    |                     +---------COMP:N-N(of)--------+-------COMP:N-N(of)-------+   
      |           +------APPOS------+              |                         +-------------COMP:N-N(of)-------------+-------------------COMP:N-N(with)-------------------+              |                     |          +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+   
      +COMP:N-N(fr+       +MOD_ATT:N+              +-COMP:N-N(with)-+COMP:N-N+                  +MOD_ATT:+COMP:N-N(o+          +MOD_ATT:N+-COMP:N-N(of)-+-COMP:N-N(with)-+-COMP:N-N(of)-+            +MOD_ATT:+          |        +MOD_ATT:N+           |       +MOD_AT+   
      |           |       |         |              |                |        |                  |        |          |          |         |              |                |              |            |        |          |        |         |           |       |      |   
 In liver from __SP__ , oral administration of __NODE__ ( with a dosage of 00.02 g/ml and a treatment period of 1 week ) and oral administration of __NODE__ ( with a dosage of 00.01 g/ml and a treatment period of 1 week ) increase expression of __SP__ __NODE__ mRNA .
COMP:N-N(from) (liver,__SP__)
COMP:N-N(of) (liver,__NODE__)
APPOS (__SP__,administration)
MOD_ATT:N-N (administration,oral)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,@card@)
COMP:N-N(of) (@card@,week)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,week)
COMP:N-N(with) (week,dosage)
MOD_ATT:N-N (administration,oral)
COMP:N-N(of) (administration,__NODE__)
COMP:N-N(with) (__NODE__,dosage)
COMP:N-N(of) (dosage,g/ml)
COMP:N-N(of) (g/ml,expression)
MOD_ATT:N-N (period,treatment)
COMP:N-N(of) (period,expression)
MOD_ATT:N-N (expression,week)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)